Jonathan Edwards, what do you think about the results from the teclistamab CD3-BCMA bispecific recently published like SLE case report (NEJM paper link) and pSS, IIM, RA and SSc (all had ILD). Do you think it could "reset" B cells memory in the same way as CAR-T (hopefully) does?
It seems that...